Skip to main content

Table 4 Functional enrichment of KEGG pathways for part of DNB

From: Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers

Term Description Genes p-value
hsa04640 Hematopoietic cell lineage CD3G, CD8A, CD3D, CD3E, IL7R, FLT3LG, CD1D, IL4R, MS4A1, CD2, CD5, CD14, HLA-DRA 3.23E-11
hsa04060 Cytokine-cytokine receptor interaction IFNAR2, TNFRSF1B, IL2RB, TNFSF10, IL18RAP, CCR5, IL4R, CCR1, TGFBR2, CXCR1, IL7R, CD27, IL17RA, FLT3LG 3.87E-07
hsa04210 Apoptosis TNFSF10, NTRK1, RIPK1, FADD, CAPN2, PIK3R2 3.82E-04
hsa05220 Chronic myeloid leukemia BCR, TGFBR2, ABL1, CRK, PIK3R2 0.005920
hsa04010 MAPK signaling pathway DUSP4, RASGRP1, NTRK1, MAP3K1, TGFBR2, CRK, CD14 0.043672
hsa04151 PI3K-Akt signaling pathway FGFR2, IFNAR2, IL2RB, CD19, IL4R, RXRA, ITGB7, PIK3CD, RAC1, JAK3, IL7R, PIK3R2 0.059021